A combination of cilostazol and Ginkgo biloba extract protects against cisplatin-induced Cochleo-vestibular dysfunction by inhibiting the mitochondrial apoptotic and ERK pathways

Cisplatin (cis-diammine-dichloroplatinum; CDDP) is an anticancer drug that induces significant hearing loss and balance dysfunction as side effects. Cilostazol (CS, 6-[4-(1-cyclohexyl-1H-tetrazol-5-yl) butoxy]-3, 4-dihydro-2-(1H)-quinolinone) has neuroprotective and antioxidant effects, whereas Gink...

Descripción completa

Detalles Bibliográficos
Autores principales: Tian, C J, Kim, Y J, Kim, S W, Lim, H J, Kim, Y S, Choung, Y-H
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2013
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3734837/
https://www.ncbi.nlm.nih.gov/pubmed/23429295
http://dx.doi.org/10.1038/cddis.2013.33

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3734837/
https://www.ncbi.nlm.nih.gov/pubmed/23429295
http://dx.doi.org/10.1038/cddis.2013.33

Ejemplares similares